Pixantrone (Pixuvri)

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search

Although this drug is EMA approved as of 5/31/2013, it is not yet FDA approved.

Mechanism of action

From the NCI Drug Dictionary: The dimaleate salt of a synthetic, noncardiotoxic aza-anthracenedione analogue with potential antineoplastic activity. Pixantrone intercalates into DNA and induces topoisomerase II-mediated DNA strand crosslinks, resulting in inhibition of DNA replication and tumor cell cytotoxicity. Route: IV

Diseases for which it is used

Also known as

  • Code name: BBR 2778
  • Generic name: pixantrone dimaleate
  • Brand name: Pixuvri